-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DhhzUhNbihxjOg48c7a1M4q+nMBCw302r87aXzqtNNcPGoWQcxtttE0tjymA+C88 GZzQXdOEo0scYFyXgwC2tQ== 0001144204-10-012523.txt : 20100310 0001144204-10-012523.hdr.sgml : 20100310 20100310161238 ACCESSION NUMBER: 0001144204-10-012523 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100308 FILED AS OF DATE: 20100310 DATE AS OF CHANGE: 20100310 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GLUSKIN ANNA E CENTRAL INDEX KEY: 0001125857 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-25169 FILM NUMBER: 10670685 MAIL ADDRESS: STREET 1: 33 HARBOUR SQUARE STE 202 CITY: TORONTO STATE: A6 ZIP: M5H2G2 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0001059784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820490211 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CANADA STATE: A1 ZIP: M5J 2G2 BUSINESS PHONE: 4163642551 MAIL ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CA STATE: A1 ZIP: M5J 2G2 4 1 v176802_ex.xml X0303 4 2010-03-08 0 0001059784 GENEREX BIOTECHNOLOGY CORP GNBT 0001125857 GLUSKIN ANNA E 33 HARBOUR SQUARE SUITE 202 TORONTO A6 M5J 2G2 ONTARIO, CANADA 1 1 0 0 CEO & President Common Stock Purchase Option (right to buy) 0.61 2009-10-20 4 D 0 250000 0 D 2009-12-12 Common Stock 250000 0 D Common Stock Purchase Option (right to buy) 0.61 2009-10-20 4 A 0 250000 0 A 2014-10-26 Common Stock 250000 250000 D Common Stock Purchase Option (right to buy) 0.001 2009-10-20 4 D 0 1120704 0 D 2010-04-05 Common Stock 1120704 0 D Common Stock Purchase Option (right to buy) 0.001 2009-10-20 4 A 0 1120704 0 A 2014-10-26 Common Stock 1120704 1120704 D Common Stock Purchase Option (right to buy) 0.64 2010-03-08 4 A 0 500000 0 A 2020-03-07 Common Stock 500000 500000 D Deemed cancellation of option in connection with deemed grant of replacement option. The reported transaction involved the extension of the term of existing options through October 26, 2014 as previously reported in the issuer's Current Report on Form 8-K filed on October 23, 2009. The option becomes exercisable in three installments, with the first installment (166,666 shares) exercisable as of the date of grant, the second installment (166,667 shares) exercisable as of August 1, 2010 and the third installment (166,667 shares) exercisable as of August 1, 2011. /s/ Anna E. Gluskin 2010-03-10 -----END PRIVACY-ENHANCED MESSAGE-----